Haffke et al. did not include ME/CFS patients that did not develop ME/CFS post COVID-19; however, whether ET-1 levels were associated with COVID-19 or related to ME/CFS too is unclear. This evidence concerns the gene EDN1 and myalgic encephalomeyelitis/chronic fatigue syndrome.